Exhibiting at Foodex Japan 2025

Taikyo Pharmaceutical Co., Ltd. – Innovating Pharmaceutical Solutions for Global Healthcare

Taikyo Pharmaceutical Co., Ltd., headquartered in Toyama, Japan, is a leading pharmaceutical manufacturer specializing in the development, production, and distribution of transdermal patches, oral medications, and liquid pharmaceutical products. With a strong commitment to research-driven innovation, regulatory excellence, and global healthcare advancements, Taikyo Pharmaceutical has established itself as a trusted supplier in the pharmaceutical industry.

Core Business and Specialization

Taikyo Pharmaceutical Co., Ltd. is dedicated to the manufacturing and distribution of high-quality pharmaceutical formulations, with expertise in:

• Transdermal Drug Delivery Systems – Advanced cataplasms, gel patches, and medical adhesive tapes for effective pain relief and treatment applications
• Oral Medications – Manufacturing hard capsules and granules for enhanced bioavailability and therapeutic efficiency
• Liquid Pharmaceutical Products – Developing mini drinks (20-50ml) and standard medicinal drinks (100ml) for fast-acting and easy consumption

Product Offerings

Taikyo Pharmaceutical Co., Ltd. delivers a diverse range of pharmaceutical and healthcare solutions, including:

• Transdermal Drug Delivery Systems

  • Cataplasms/Gel Patches
  • Medical Tapes

• Oral Medications

  • Hard Capsules
  • Granules

• Liquid Pharmaceuticals

  • Mini Medicinal Drinks (20-50ml)
  • Standard Medicinal Drinks (100ml)

Market Presence and Global Distribution

Taikyo Pharmaceutical Co., Ltd. has built a strong market presence, supplying its products to:

• Hospitals & Healthcare Providers – Delivering high-quality pharmaceutical formulations for patient care
• Pharmaceutical Distributors & Wholesalers – Ensuring efficient supply chain management for global distribution
• Contract Manufacturing & OEM Clients – Offering customized pharmaceutical production solutions
• Retail & Pharmacy Chains – Expanding accessibility of prescription and over-the-counter medications

The global pharmaceutical industry is valued at over $1.48 trillion, with Japan ranking third in the global pharmaceutical market. Taikyo Pharmaceutical is positioned to leverage growing demand for innovative drug formulations.

Financial Strength and Business Growth

Taikyo Pharmaceutical Co., Ltd. has demonstrated strong revenue growth and market expansion, driven by:

• Rising demand for transdermal drug delivery systems, with a CAGR of 9.5% in global pain management markets
• Increased investment in contract manufacturing (OEM) services, strengthening international pharmaceutical partnerships
• Advanced formulation technologies in oral and liquid medications, ensuring enhanced drug efficacy and patient compliance

Certifications and Compliance

To maintain high-quality manufacturing standards and regulatory compliance, Taikyo Pharmaceutical Co., Ltd. adheres to:

• GMP (Good Manufacturing Practices) Certification – Ensuring pharmaceutical production safety and efficiency
• ISO 9001 & ISO 13485 Compliance – Meeting global medical device and pharmaceutical manufacturing standards
• PMDA (Pharmaceuticals and Medical Devices Agency) Approval – Aligning with Japan’s strict pharmaceutical regulatory framework
• FDA & EMA Compliance – Ensuring global pharmaceutical market approvals for North America and the European Union

Export and Shipment Performance

Taikyo Pharmaceutical Co., Ltd. maintains a strong international export network, supplying products to:

• North America & Europe – Expanding into advanced pharmaceutical and healthcare markets
• Asia-Pacific – Strengthening presence in emerging economies with growing healthcare investments
• Middle East & Latin America – Increasing export volumes of transdermal patches and liquid medications

With cutting-edge manufacturing facilities and a well-integrated logistics system, the company ensures timely and high-quality pharmaceutical deliveries worldwide.

Brand Strength and Recognition

Taikyo Pharmaceutical Co., Ltd. is recognized for:

• Industry leadership in transdermal drug delivery innovations, offering effective pain relief and therapeutic patches
• Commitment to pharmaceutical research and development, ensuring safe, effective, and high-quality medications
• Strong global partnerships with leading healthcare providers and pharmaceutical companies

Customer Testimonials

• "Taikyo Pharmaceutical's gel patches provide excellent pain relief and adhere well, making them a top choice for our medical facilities." – Healthcare Supplier
• "Their granule formulations are superior in solubility and absorption, making them a trusted solution for pharmaceutical distributors." – Pharmaceutical Research Scientist

Major Achievements

• Expanded pharmaceutical exports to over 30 countries, reinforcing global market leadership
• Recognition for cutting-edge drug formulation and pharmaceutical innovation
• Continuous investment in R&D and medical technology, ensuring high-quality and patient-centric pharmaceutical solutions

With a commitment to quality, innovation, and international healthcare advancement, Taikyo Pharmaceutical Co., Ltd. continues to be a leader in pharmaceutical manufacturing, delivering trusted solutions for patients and healthcare professionals worldwide.